Alpha lipoic acid for peripheral neuropathy, do you still recommend ?

By Rachel Poencet in 1 Jul 2021 | 16:25
Rachel Poencet

Rachel Poencet

Student
Posts: 5
Member since: 1 Sep 2020
David, This metaanalysis -- basically showed the best results w/ the study that used 600 mg IV x 3 wks. Then I believe there were only two other studies that met their incluson criteria. There did not appear to be in any increased benefit over 600 mg per day. There was also a very strong placebo effect (one could also argue an even stronger placebo effect by giving a person and IV! every day). The review also points out some interesting conflicts of interest -- most of studies done by same German group which is paid by the supp company. a company advisor also sat on the study advisory board. Where does your recommendation stand w/ ALA, and what dose? Also, I can't remember if you had a few herbs that you tended to put into formulas for diabetic peripheral neuropathy. I know everyone is different. Int J Endocrinol. 2012; 2012: 456279. Published online 2012 Jan 26. doi: 10.1155/2012/456279 PMCID: PMC3272801 PMID: 22331979 Alpha Lipoic Acid for Symptomatic Peripheral Neuropathy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials Gerritje S. Mijnhout, 1 ,* Boudewijn J. Kollen, 2 Alaa Alkhalaf, 1 , 3 , 4 Nanno Kleefstra, 3 , 4 , 5 and Henk J. G. Bilo 1 , 3 , 4
1 Jul 2021 | 16:25
0 Likes
David Winston

David Winston

Instructor
Posts: 858
Member since: 22 Sep 2020
I use 250 mg BID of an alpha-lipoid acid from a company called Reliance (they are a private labeler and the product is usually sold by the store name). The product is a Japanese ALA and I get better results with it than other products I have tried. For diabetic neuropathy I also use herbs such as St John’s wort, Prickly Ash, Cinnamon twig (Gui Zhi) and the supplement PEA. Int J Endocrinol. 2012; 2012: 456279. Published online 2012 Jan 26. doi: 10.1155/2012/456279 PMCID: PMC3272801 PMID: 22331979 Alpha Lipoic Acid for Symptomatic Peripheral Neuropathy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials Gerritje S. Mijnhout, 1 ,* Boudewijn J. Kollen, 2 Alaa Alkhalaf, 1 , 3 , 4 Nanno Kleefstra, 3 , 4 , 5 and Henk J. G. Bilo 1 , 3 , 4
8 Jul 2021 | 20:08
0 Likes

Report

Please describe about the report short and clearly.

GDPR

When you visit any of our websites, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and manage your preferences. Please note, that blocking some types of cookies may impact your experience of the site and the services we are able to offer.